Study details
Enrolling now
ACT Intervention for Type 2 Diabetes Management
Sam Houston State University
NCT IDNCT06028503ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 3.4 years
Ages
18+
Locations
1 site in TX
About this study
This trial is testing a new way to manage type 2 diabetes using Acceptance and Commitment Therapy (ACT), Continuous Glucose Monitoring (CGM), and lifestyle education. The goal is to see if this approach improves diabetes outcomes in rural communities compared to standard care.
Based on ClinicalTrials.gov records.
What participants do
- 1.Generic Education
- 2.Participate in Acceptance and Commitment Therapy
- 3.Use Abbott FreeStyle® Libre® 3
Primary goalReduction in Hemoglobin A1C
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Reduction in Hemoglobin A1C
Secondary: Adherence, Body Composition, Body Mass Index, Depression
Devices
monitoring
Body systems
Endocrinology